Michl Binderbauer
PRESIDENT, CHIEF TECHNOLOGY OFFICER, TAE LIFE SCIENCES
Spinout of parent TAE Technologies Inc. … backed by $40M 2018 Series A round led by Artis Ventures … kills cancer cells via energy beams … ‘boron neutron capture therapy’ targets inoperable tumors … first customer China-based oncology center … ‘two decades of research … repurposed for medical’ … nuclear fusion … massive energy use … $100M to build system
